CLINICAL_TRIALS
trial_result
· 2011-01-25
Clinical Trial Update: GW786034 In Subjects With Locally Recurrent Or Metastatic Clear Cell Renal Cell Carcinoma [Phase 2]
Summary
Phase 2 trial of GW786034 in locally recurrent or metastatic clear cell renal cell carcinoma has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Carcinoma, Renal Cell | Phase 2 | Status: COMPLETED | Results posted: 2011-01-25